Disclaimer

Terms of Use

All content of this Internet site is owned or controlled by Recro Pharma, Inc. and is protected by worldwide copyright laws. You may download content only for your personal use for non-commercial purposes but no modification or further reproduction of the content is permitted. The content may otherwise not be copied or used in any way.

Recro will use reasonable efforts to include up-to-date and accurate information in this Internet site, but make no representations, warranties, or assurances as to the accuracy, currency, or completeness of the information provided. The owners of this site shall not be liable for any damages or injury resulting from your access to, or inability to access, this Internet site, or from your reliance on any information provided at this Internet site.

This Internet site may provide links or references to other sites but the owners of this site have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

The trademarks, trade names and products in this Internet site are protected in the United States and internationally. No use of any of these may be made without the prior, written authorization of the owners of this site, except to identify the products or services of the Recro.

Any personally identifiable information in electronic communications to this Internet site is governed by this site’s Privacy Policy. Recro shall be free to use or copy all other information in any such communications, including any ideas, inventions, concepts, techniques or know-how disclosed therein, for any purposes. Such purposes may include disclosure to third parties and/or developing, manufacturing and/or marketing goods or services.

The sender of any communications to this Internet site or otherwise to Recro shall be responsible for the content and information contained therein, including its truthfulness and accuracy.

Caution Regarding Forward-Looking Statements

This Internet site contains forward-looking statements that involve risks and uncertainties. Such forward looking statements reflect Recro’s expectations about its future performance and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target”, “intend” and “expect” and similar expressions, as they relate to Recro or its management, are intended to identify such forward-looking statements. These forward looking statements are based on information available to Recro as of the date of publication on this Internet site and are subject to a number of risks, uncertainties, and other factors that could cause Recro’s performance to differ materially from those expressed in, or implied by, these forward looking statements. Recro assumes no obligation to update any such forward-looking statements. Factors that could cause Recro’s actual performance to materially differ from those expressed in the forward-looking statements set forth on this Internet site include, without limitation: results and timing of the clinical trials of injectable Meloxicam and Dex-IN; the ability to obtain and maintain regulatory approval of injectable Meloxicam and Dex-IN, and the labeling under any such approval; regulatory developments in the United States and foreign countries; the Recro’s ability to raise future financing for continued development; the Recro’s ability to pay its debt; the performance of third-party suppliers and manufacturers; the Recro’s ability to obtain, maintain and successfully enforce adequate patent and other intellectual property protection; and the successful commercialization of injectable Meloxicam and Dex-IN. In addition, the forward looking statements in this Internet site should be considered together with the risks and uncertainties that may affect Recro’s business and future results included in Recro’s filings with the Securities and Exchange Commission at www.sec.gov. Recro assumes no obligation to update any such forward looking statements.